The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Blueprint Medicines Corp shares valued at $216,348 were sold by Rossi Christina on Feb 20 ’25. At $95.14 per share, Rossi Christina sold 2,274 shares. The insider’s holdings dropped to 64,835 shares worth approximately $5.93 million following the completion of this transaction.
Also, Haviland Kate sold 1,446 shares, netting a total of over 159,407 in proceeds. Following the sale of shares at $110.24 each, the insider now holds 149,378 shares.
Before that, Rossi Christina had sold 2,274 shares from its account. In a trade valued at $250,455, the CHIEF OPERATING OFFICER traded Blueprint Medicines Corp shares for $110.14 each. Upon closing the transaction, the insider’s holdings decreased to 2,274 shares, worth approximately $6.13 million.
As published in their initiating research note from JP Morgan on November 14, 2024, Blueprint Medicines Corp [BPMC] has been an Overweight and the price target has been revised to $126. Analysts at UBS started covering the stock with ‘”a Neutral”‘ outlook in a report released in late October. As of May 14, 2024, Stephens has initiated its “an Overweight” rating for BPMC. Earlier on May 06, 2024, Leerink Partners upgraded its rating. Their new recommendation was “a Market perform” for BPMC stock which previously was a “an Underperform”.
Analyzing BPMC Stock Performance
During the last five days, there has been a drop of approximately -2.84%. Over the course of the year, Blueprint Medicines Corp shares have jumped approximately 4.79%. Shares of the company reached a 52-week high of $118.25 on 01/27/25 and a 52-week low of $86.72 on 01/10/25. A 50-day SMA is recorded $99.32, while a 200-day SMA reached $98.40. Nevertheless, trading volume fell to 0.56 million shares from 0.69 million shares the previous day.
Support And Resistance Levels for Blueprint Medicines Corp (BPMC)
According to the 24-hour chart, there is a support level at 90.47, which, if violated, would cause prices to drop to 89.55. In the upper region, resistance lies at 92.51. The next price resistance is at 93.63. RSI (Relative Strength Index) is 33.41 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -5.51, which suggests the price will decrease in the coming days. Percent R is at 96.53%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
